Reply to correspondence on “Adverse impact of metabolic dysfunction on fibrosis regression following direct-acting antiviral therapy: A multicenter study for chronic hepatitis C”
Saved in:
| Main Authors: | , |
|---|---|
| Format: | Article |
| Language: | English |
| Published: |
Korean Association for the Study of the Liver
2025-04-01
|
| Series: | Clinical and Molecular Hepatology |
| Subjects: | |
| Online Access: | http://e-cmh.org/upload/pdf/cmh-2025-0203.pdf |
| Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
| _version_ | 1850196945184751616 |
|---|---|
| author | Chen-Hua Liu Yu-Ping Chang |
| author_facet | Chen-Hua Liu Yu-Ping Chang |
| author_sort | Chen-Hua Liu |
| collection | DOAJ |
| format | Article |
| id | doaj-art-e9e2f70cd3c54c37b2b0c978bb228c4b |
| institution | OA Journals |
| issn | 2287-2728 2287-285X |
| language | English |
| publishDate | 2025-04-01 |
| publisher | Korean Association for the Study of the Liver |
| record_format | Article |
| series | Clinical and Molecular Hepatology |
| spelling | doaj-art-e9e2f70cd3c54c37b2b0c978bb228c4b2025-08-20T02:13:19ZengKorean Association for the Study of the LiverClinical and Molecular Hepatology2287-27282287-285X2025-04-01312e232e23310.3350/cmh.2025.02032197Reply to correspondence on “Adverse impact of metabolic dysfunction on fibrosis regression following direct-acting antiviral therapy: A multicenter study for chronic hepatitis C”Chen-Hua Liu0Yu-Ping Chang1 Department of Internal Medicine, National Taiwan University Hospital, Taipei, Taiwan Department of Internal Medicine, National Taiwan University Biomedical Park Hospital, Hsin-Chu, Taiwanhttp://e-cmh.org/upload/pdf/cmh-2025-0203.pdfhepatitis chepatic fibrosisnoninvasive testsustained virologic responsedirect-acting antiviral |
| spellingShingle | Chen-Hua Liu Yu-Ping Chang Reply to correspondence on “Adverse impact of metabolic dysfunction on fibrosis regression following direct-acting antiviral therapy: A multicenter study for chronic hepatitis C” Clinical and Molecular Hepatology hepatitis c hepatic fibrosis noninvasive test sustained virologic response direct-acting antiviral |
| title | Reply to correspondence on “Adverse impact of metabolic dysfunction on fibrosis regression following direct-acting antiviral therapy: A multicenter study for chronic hepatitis C” |
| title_full | Reply to correspondence on “Adverse impact of metabolic dysfunction on fibrosis regression following direct-acting antiviral therapy: A multicenter study for chronic hepatitis C” |
| title_fullStr | Reply to correspondence on “Adverse impact of metabolic dysfunction on fibrosis regression following direct-acting antiviral therapy: A multicenter study for chronic hepatitis C” |
| title_full_unstemmed | Reply to correspondence on “Adverse impact of metabolic dysfunction on fibrosis regression following direct-acting antiviral therapy: A multicenter study for chronic hepatitis C” |
| title_short | Reply to correspondence on “Adverse impact of metabolic dysfunction on fibrosis regression following direct-acting antiviral therapy: A multicenter study for chronic hepatitis C” |
| title_sort | reply to correspondence on adverse impact of metabolic dysfunction on fibrosis regression following direct acting antiviral therapy a multicenter study for chronic hepatitis c |
| topic | hepatitis c hepatic fibrosis noninvasive test sustained virologic response direct-acting antiviral |
| url | http://e-cmh.org/upload/pdf/cmh-2025-0203.pdf |
| work_keys_str_mv | AT chenhualiu replytocorrespondenceonadverseimpactofmetabolicdysfunctiononfibrosisregressionfollowingdirectactingantiviraltherapyamulticenterstudyforchronichepatitisc AT yupingchang replytocorrespondenceonadverseimpactofmetabolicdysfunctiononfibrosisregressionfollowingdirectactingantiviraltherapyamulticenterstudyforchronichepatitisc |